Globe Life Inc. GL
We take great care to ensure that the data presented and summarized in this overview for GLOBE LIFE INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GL
View all-
Vanguard Group Inc Valley Forge, PA11.2MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.1MShares$664 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$521 Million0.09% of portfolio
-
Invesco Ltd. Atlanta, GA3.71MShares$403 Million0.08% of portfolio
-
State Street Corp Boston, MA3.55MShares$386 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA2.62MShares$285 Million0.02% of portfolio
-
Morgan Stanley New York, NY1.74MShares$189 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.52MShares$165 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.47MShares$160 Million0.04% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.25MShares$136 Million0.11% of portfolio
Latest Institutional Activity in GL
Top Purchases
Top Sells
About GL
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Insider Transactions at GL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Rebecca E Zorn EVP & Chief Talent Officer |
SELL
Bona fide gift
|
Direct |
112
-1.1%
|
-
|
|
Oct 30
2024
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Bona fide gift
|
Indirect |
330
+17.4%
|
-
|
|
Oct 30
2024
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Bona fide gift
|
Indirect |
660
-1.58%
|
-
|
|
Jul 26
2024
|
Mary E Thigpen Director |
BUY
Open market or private purchase
|
Direct |
3,000
+16.12%
|
$270,000
$90.2 P/Share
|
|
Jun 04
2024
|
James Matthew Darden Co-Chairman & CEO |
BUY
Discretionary transaction
|
Indirect |
2,579
+38.26%
|
$208,899
$81.81 P/Share
|
|
May 28
2024
|
Robert Edward Hensley EVP & Chief Investment Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+25.54%
|
$205,000
$82.17 P/Share
|
|
May 21
2024
|
James Matthew Darden Co-Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+2.5%
|
$82,000
$82.78 P/Share
|
|
May 21
2024
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
2,500
+1.7%
|
$205,000
$82.27 P/Share
|
|
May 20
2024
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
2,500
+1.73%
|
$215,000
$86.31 P/Share
|
|
May 17
2024
|
Thomas Peter Kalmbach EVP & CFO |
BUY
Open market or private purchase
|
Direct |
500
+2.69%
|
$42,000
$84.43 P/Share
|
|
May 16
2024
|
James Matthew Darden Co-Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+5.0%
|
$168,000
$84.82 P/Share
|
|
Apr 25
2024
|
Mark A Blinn Director |
BUY
Open market or private purchase
|
Direct |
2,000
+23.48%
|
$152,000
$76.77 P/Share
|
|
Apr 25
2024
|
Rebecca E Zorn EVP & Chief Talent Officer |
SELL
Open market or private sale
|
Direct |
2,320
-18.5%
|
$178,640
$77.3 P/Share
|
|
Apr 24
2024
|
Steven Paul Johnson Director |
BUY
Open market or private purchase
|
Indirect |
1,319
+8.2%
|
$100,244
$76.42 P/Share
|
|
Apr 24
2024
|
David A Rodriguez Director |
BUY
Open market or private purchase
|
Direct |
1,500
+26.35%
|
$118,500
$79.72 P/Share
|
|
Apr 24
2024
|
James Brannen Director |
BUY
Open market or private purchase
|
Direct |
2,000
+22.15%
|
$156,000
$78.47 P/Share
|
|
Feb 28
2024
|
James Matthew Darden Co-Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,066
-10.16%
|
$520,448
$128.4 P/Share
|
|
Feb 28
2024
|
James Matthew Darden Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,795
+15.49%
|
-
|
|
Feb 28
2024
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,108
-21.18%
|
$269,824
$128.4 P/Share
|
|
Feb 28
2024
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Grant, award, or other acquisition
|
Direct |
8,635
+37.51%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 86.8K shares |
|---|---|
| Open market or private purchase | 20.8K shares |
| Exercise of conversion of derivative security | 61.8K shares |
| Bona fide gift | 610 shares |
| Discretionary transaction | 2.58K shares |
| Bona fide gift | 1.34K shares |
|---|---|
| Open market or private sale | 55.3K shares |
| Payment of exercise price or tax liability | 19.8K shares |